117 related articles for article (PubMed ID: 9832283)
1. Susceptibility of adherent organisms from Pseudomonas aeruginosa and Staphylococcus aureus strains isolated from burn wounds to antimicrobial agents.
Trafny EA
Int J Antimicrob Agents; 1998 Aug; 10(3):223-8. PubMed ID: 9832283
[TBL] [Abstract][Full Text] [Related]
2. Adhesion of Pseudomonas aeruginosa to collagen biomaterials: effect of amikacin and ciprofloxacin on the colonization and survival of the adherent organisms.
Trafny EA; Kowalska K; Grzybowski J
J Biomed Mater Res; 1998 Sep; 41(4):593-9. PubMed ID: 9697032
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ
Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068
[TBL] [Abstract][Full Text] [Related]
4. Determination of minimal regrowth concentration (MRC) in clinical isolates of various biofilm-forming bacteria.
Cernohorská L; Votava M
Folia Microbiol (Praha); 2004; 49(1):75-8. PubMed ID: 15114870
[TBL] [Abstract][Full Text] [Related]
5. An in vitro biofilm model to examine the effect of antibiotic ointments on biofilms produced by burn wound bacterial isolates.
Hammond AA; Miller KG; Kruczek CJ; Dertien J; Colmer-Hamood JA; Griswold JA; Horswill AR; Hamood AN
Burns; 2011 Mar; 37(2):312-21. PubMed ID: 21130579
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of distribution and drug resistance of pathogens from the wounds of 1 310 thermal burn patients].
Zhang C; Gong YL; Luo XQ; Liu MX; Peng YZ
Zhonghua Shao Shang Za Zhi; 2018 Nov; 34(11):802-808. PubMed ID: 30481922
[No Abstract] [Full Text] [Related]
7. In vitro production of biofilm in a flow cell system in a strain of Pseudomonas aeruginosa and Staphylococcus aureus and determination of efficiency of ciprofloxacin against them.
Gupta S; Agarwal S; Sahoo DR; Muralidharan S
Indian J Pathol Microbiol; 2011; 54(3):569-71. PubMed ID: 21934223
[TBL] [Abstract][Full Text] [Related]
8. RX-P873, a Novel Protein Synthesis Inhibitor, Accumulates in Human THP-1 Monocytes and Is Active against Intracellular Infections by Gram-Positive (Staphylococcus aureus) and Gram-Negative (Pseudomonas aeruginosa) Bacteria.
Buyck JM; Peyrusson F; Tulkens PM; Van Bambeke F
Antimicrob Agents Chemother; 2015 Aug; 59(8):4750-8. PubMed ID: 26014952
[TBL] [Abstract][Full Text] [Related]
9. Peganum harmalapeptides (PhAMP) impede bacterial growth and biofilm formation in burn and surgical wound pathogens.
Khalid R; Jaffar Q; Tayyeb A; Qaisar U
Pak J Pharm Sci; 2018 Nov; 31(6 (Supplementary):2597-2605. PubMed ID: 30587467
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic activity of the haematoporphyrin derivative with rutin and arginine substituents (HpD-Rut(2)-Arg(2)) against Staphylococcus aureus and Pseudomonas aeruginosa.
Szpakowska M; Lasocki K; Grzybowski J; Graczyk A
Pharmacol Res; 2001 Sep; 44(3):243-6. PubMed ID: 11529692
[TBL] [Abstract][Full Text] [Related]
11. The antimicrobial spectrum of Xeroform
Barillo DJ; Barillo AR; Korn S; Lam K; Attar PS
Burns; 2017 Sep; 43(6):1189-1194. PubMed ID: 28641915
[TBL] [Abstract][Full Text] [Related]
12. [Resistance of Staphylococcus aureus isolated from burn wounds to antibiotics].
Grigaite R; Pavilonis A; Rimdeika R; Antusevas A
Medicina (Kaunas); 2006; 42(5):377-83. PubMed ID: 16778465
[TBL] [Abstract][Full Text] [Related]
13. Pseudomonas aeruginosa prevalence, antibiotic resistance and antimicrobial use in Chinese burn wards from 2007 to 2014.
Dou Y; Huan J; Guo F; Zhou Z; Shi Y
J Int Med Res; 2017 Jun; 45(3):1124-1137. PubMed ID: 28443385
[TBL] [Abstract][Full Text] [Related]
14. [Investigation of acquired drug-resistant genes and strains relationship in
Fan YF; Cui SY; Zhang C; Xu XM
Zhonghua Shao Shang Za Zhi; 2018 Feb; 34(2):83-87. PubMed ID: 29973025
[No Abstract] [Full Text] [Related]
15. A model for testing drug susceptibility of Pseudomonas aeruginosa and Staphylococcus aureus grown in biofilms on medical devices.
Kétyi I
Acta Microbiol Immunol Hung; 1995; 42(2):215-9. PubMed ID: 7551716
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of the predominant bacterial strains on burn wound during early postburn stage].
Li TZ; Luo L; Xu YB; Deng XX; Liu S; Fan GY; Qi SH
Zhonghua Shao Shang Za Zhi; 2003 Apr; 19(2):71-4. PubMed ID: 12812628
[TBL] [Abstract][Full Text] [Related]
17. In-vitro investigation of the antibacterial activity of agents which may be used for the oral treatment of lung infections in CF patients.
Richards RM; Hamilton VE; Thomas MR
J Antimicrob Chemother; 1998 Aug; 42(2):171-8. PubMed ID: 9738834
[TBL] [Abstract][Full Text] [Related]
18. Release of antibiotics from collagen dressing.
Grzybowski J; Antos-Bielska M; Ołdak E; Trafny EA
Polim Med; 1997; 27(3-4):3-9. PubMed ID: 9513248
[TBL] [Abstract][Full Text] [Related]
19. Melittin and its potential in the destruction and inhibition of the biofilm formation by Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa isolated from bovine milk.
Picoli T; Peter CM; Zani JL; Waller SB; Lopes MG; Boesche KN; Vargas GDÁ; Hübner SO; Fischer G
Microb Pathog; 2017 Nov; 112():57-62. PubMed ID: 28943153
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of distribution and drug resistance of pathogens of burn patients during 9 years].
Dou Y; Zhang Q
Zhonghua Shao Shang Za Zhi; 2018 Mar; 34(3):153-159. PubMed ID: 29609277
[No Abstract] [Full Text] [Related]
[Next] [New Search]
